Journal: Sci Adv / Year: 2024 Title: Structural basis for regulation of a CBASS-CRISPR-Cas defense island by a transmembrane anti-σ factor and its ECF σ partner. Authors: Diego Bernal-Bernal / David Pantoja-Uceda / Jorge Pedro López-Alonso / Alfonso López-Rojo / José Antonio López-Ruiz / Marisa Galbis-Martínez / Borja Ochoa-Lizarralde / Igor Tascón / ...Authors: Diego Bernal-Bernal / David Pantoja-Uceda / Jorge Pedro López-Alonso / Alfonso López-Rojo / José Antonio López-Ruiz / Marisa Galbis-Martínez / Borja Ochoa-Lizarralde / Igor Tascón / Montserrat Elías-Arnanz / Iban Ubarretxena-Belandia / S Padmanabhan / Abstract: How CRISPR-Cas and cyclic oligonucleotide-based antiphage signaling systems (CBASS) are coordinately deployed against invaders remains unclear. We show that a locus containing two CBASS and one type ...How CRISPR-Cas and cyclic oligonucleotide-based antiphage signaling systems (CBASS) are coordinately deployed against invaders remains unclear. We show that a locus containing two CBASS and one type III-B CRISPR-Cas system, regulated by the transmembrane anti-σ DdvA and its cognate extracytoplasmic function (ECF) σ DdvS, can defend against a phage. Cryo-electron microscopy reveals DdvA-DdvS pairs assemble as arrow-shaped transmembrane dimers. Each DdvA periplasmic domain adopts a separase/craspase-type tetratricopeptide repeat (TPR)-caspase HetF-associated with TPR (TPR-CHAT) architecture with an incomplete His-Cys active site, lacking three α-helices conserved among CHAT domains. Each active site faces the dimer interface, raising the possibility that signal-induced caspase-like DdvA autoproteolysis in trans precedes RseP-mediated intramembrane proteolysis and DdvS release. Nuclear magnetic resonance reveals a DdvA cytoplasmic CHCC-type zinc-bound three-helix bundle that binds to DdvS σ and σ domains, undergoing σ-induced helix extension to trap DdvS. Altogether, we provide structural-mechanistic insights into membrane anti-σ-ECF σ regulation of an antiviral CBASS-CRISPR-Cas defense island.
Mass: 65.409 Da / Num. of mol.: 1 / Source method: obtained synthetically / Formula: Zn / Feature type: SUBJECT OF INVESTIGATION
Has ligand of interest
Y
Has protein modification
N
-
Experimental details
-
Experiment
Experiment
Method: SOLUTION NMR
NMR experiment
Conditions-ID
Experiment-ID
Solution-ID
Sample state
Spectrometer-ID
Type
1
1
2
isotropic
1
2D 1H-15N HSQC
1
2
2
isotropic
1
2D 1H-13C HSQC
1
3
2
isotropic
1
3D HNCO
1
4
2
isotropic
1
3DHN(CA)CO
1
5
2
isotropic
1
3D HNCA
1
6
2
isotropic
1
3D HN(CA)CB
1
7
2
isotropic
1
3DCBCA(CO)NH
1
8
2
isotropic
1
3DH(CCO)NH
1
9
2
isotropic
1
3D (H)CC(CO)NH
1
10
2
isotropic
1
3D HNHA
1
11
2
isotropic
1
3DHBHA(CO)NH
1
12
2
isotropic
1
3D (H)N(COCA)NH
1
13
2
isotropic
1
3DH(MCOCA)NH
1
14
2
isotropic
1
2D NOESY
1
15
2
isotropic
1
2D TOCSY
1
16
2
isotropic
1
3D 1H-15N NOESY
1
17
2
isotropic
1
2D NOESY
1
18
2
isotropic
1
2D TOCSY
-
Sample preparation
Details
Type
Solution-ID
Contents
Details
Label
Solvent system
solution
1
0.7 mM [U-13C; U-15N] DdvANt, 100 mM sodium chloride, 20 mM Tris, 2 mM beta-mercaptoethanol, 0.05 % sodium azide, 90% H2O/10% D2O
DdvANtsampleforassignment
13C_15N_sample
90% H2O/10% D2O
solution
2
0.7 mM DdvANt, 100 mM sodium chloride, 20 mM Tris, 2 mM beta-mercaptoethanol, 0.05 % sodium azide, 90% H2O/10% D2O
DdvANtsampleforassignmentandstructurecalculation
1H_sample
90% H2O/10% D2O
Sample
Conc. (mg/ml)
Component
Isotopic labeling
Solution-ID
0.7mM
DdvANt
[U-13C; U-15N]
1
100mM
sodiumchloride
naturalabundance
1
20mM
Tris
naturalabundance
1
2mM
beta-mercaptoethanol
naturalabundance
1
0.05 %
sodiumazide
naturalabundance
1
0.7mM
DdvANt
naturalabundance
2
100mM
sodiumchloride
naturalabundance
2
20mM
Tris
naturalabundance
2
2mM
beta-mercaptoethanol
naturalabundance
2
0.05 %
sodiumazide
naturalabundance
2
Sample conditions
Details: DdvANt sample for assignment and structure calculation Ionic strength: 100 mM / Label: condition_1 / pH: 7.0 Not defined / Pressure: 1 atm / Temperature: 298 K
-
NMR measurement
NMR spectrometer
Type: Bruker AVANCE NEO / Manufacturer: Bruker / Model: AVANCE NEO / Field strength: 800 MHz
In the structure databanks used in Yorodumi, some data are registered as the other names, "COVID-19 virus" and "2019-nCoV". Here are the details of the virus and the list of structure data.
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)
EMDB accession codes are about to change! (news from PDBe EMDB page)
The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
The EM Navigator/Yorodumi systems omit the EMD- prefix.
Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator
Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.
Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi